High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma
Clinical trial NCT01237951 · COMPLETED
Trial details
- NCT number
- NCT01237951
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-08
- Primary completion
- 2017-09-20
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.